Search research articles
Contact Us
Filters
Showing results (201-210 of 225) with videos related to
Page
of 23
Sort By:
Kidney International Reports
|
February 14, 2022
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
Elisabeth L Metry, Sander F Garrelfs, Hessel Peters-Sengers, et al.
Transplantation
|
April 25, 2007
A report of the Lisbon Conference on the care of the kidney transplant recipient
Mario Abbud-Filho, Patricia L Adams, Josefina Alberú, et al.
Transplantation
|
November 14, 2008
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids
Gisela Offner, Burkhard Toenshoff, Britta Höcker, et al.
Nephrologie & Therapeutique
|
February 3, 2021
[Recommendations for management of patients from pediatrics unit to adult unit: Transition and transfer program]
Sandrine Lemoine, Jennifer Radenac, Véronique Baudouin, et al.
Journal of the American Society of Nephrology : JASN
|
April 14, 2006
Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene
Rosa Vargas-Poussou, Pascal Houillier, Nelly Le Pottier, et al.
Kidney International
|
June 26, 2016
Observations of a large Dent disease cohort
Anne Blanchard, Emmanuel Curis, Tiphaine Guyon-Roger, et al.
European Journal of Human Genetics : EJHG
|
September 5, 2019
School level of children carrying a HNF1B variant or a deletion
Fanny Laliève, Stéphane Decramer, Laurence Heidet, et al.
Kidney International
|
December 15, 2011
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Oliver Gross, Christoph Licht, Hans J Anders, et al.
Kidney International Reports
|
October 18, 2023
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
Elisabeth L Metry, Sander F Garrelfs, Lisa J Deesker, et al.
The New England Journal of Medicine
|
March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 225) with videos related to
Sort By:
Page
of 23
Kidney International Reports
|
February 14, 2022
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
Elisabeth L Metry, Sander F Garrelfs, Hessel Peters-Sengers, et al.
Transplantation
|
April 25, 2007
A report of the Lisbon Conference on the care of the kidney transplant recipient
Mario Abbud-Filho, Patricia L Adams, Josefina Alberú, et al.
Transplantation
|
November 14, 2008
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids
Gisela Offner, Burkhard Toenshoff, Britta Höcker, et al.
Nephrologie & Therapeutique
|
February 3, 2021
[Recommendations for management of patients from pediatrics unit to adult unit: Transition and transfer program]
Sandrine Lemoine, Jennifer Radenac, Véronique Baudouin, et al.
Journal of the American Society of Nephrology : JASN
|
April 14, 2006
Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene
Rosa Vargas-Poussou, Pascal Houillier, Nelly Le Pottier, et al.
Kidney International
|
June 26, 2016
Observations of a large Dent disease cohort
Anne Blanchard, Emmanuel Curis, Tiphaine Guyon-Roger, et al.
European Journal of Human Genetics : EJHG
|
September 5, 2019
School level of children carrying a HNF1B variant or a deletion
Fanny Laliève, Stéphane Decramer, Laurence Heidet, et al.
Kidney International
|
December 15, 2011
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Oliver Gross, Christoph Licht, Hans J Anders, et al.
Kidney International Reports
|
October 18, 2023
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
Elisabeth L Metry, Sander F Garrelfs, Lisa J Deesker, et al.
The New England Journal of Medicine
|
March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.
Page
of 23